Retinoblastoma in Jordan, 2003–2013: Ocular Survival and Associated Factors
Authors:
- Ibrahim Al-NawaisehIAIbrahim Al-Nawaiseh
- Hisham M. JammalHJHisham M. Jammal
- Yousef S. KhaderYousef S. Khader
- Imad JaradatIJImad Jaradat
- Rasha BarhamRBRasha Barham
- 15 October 2014
- journal article
- Published by Taylor & Francis in Ophthalmic Epidemiology
- Vol. 21 (6) , 406-411
Abstract
To determine ocular survival and factors affecting globe survival in patients diagnosed with retinoblastoma at King Hussein Cancer Center (KHCC). A retrospective review of medical records of 71 Jordanian patients (45 males and 26 females) diagnosed with retinoblastoma (114 eyes) between June 2003 and May 2013 was conducted. Patient sociodemographic and relevant characteristics were collected from records. Patients with bilateral retinoblastoma were treated with chemoreduction and focal consolidation. Lens-sparing radiation therapy and enucleation were reserved for eyes that failed chemoreduction combined with focal therapy. In cases of unilateral retinoblastoma, primary enucleation was recommended for eyes with advanced unilateral disease (Reese-Ellsworth classification groups IV and V). Kaplan-Meier survival and Cox regression multilevel analysis were used to analyze the data. Median age at diagnosis was 12 months. The follow-up period ranged from 0.25-160 months (mean 26.9 months). The Kaplan-Meier estimate of globe survival of the 114 eyes was 68.0% at 1 year, 63.3% at 2 years, and 62.1% at 5 years. The mean survival time was 101.6 months (95% confidence interval, CI, 87.6-115.6 months). In multivariable-adjusted analysis, advanced stage of the disease (hazard ratio, HR, 5.1, 95% CI 2.3-11.6), unilateral disease (HR 3.3, 95% CI 1.4-8.1), and delay in diagnosis (HR 2.4, 95% CI 1.1-5.5) were significantly associated with increased hazard of enucleation. The overall ocular survival rate for eyes with retinoblastoma was close to regional and international figures. Disease stage, laterality, and delay in diagnosis were significant predictors of enucleation.Keywords
This publication has 17 references indexed in Scilit:
- Retinoblastoma in JordanHematology/Oncology and Stem Cell Therapy, 2011
- Strategies to manage retinoblastoma in developing countriesPediatric Blood & Cancer, 2010
- Enucleation for retinoblastoma: the experience of a single center in JordanInternational Ophthalmology, 2010
- Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survivalBritish Journal of Ophthalmology, 2008
- Incidence of retinoblastoma in the USA: 1975-2004British Journal of Ophthalmology, 2008
- CONTINUING CHALLENGES IN THE MANAGEMENT OF RETINOBLASTOMA WITH CHEMOTHERAPYRetina, 2004
- UPDATE ON RETINOBLASTOMARetina, 2004
- Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing countryPediatric Blood & Cancer, 2004
- Incidence of retinoblastoma from 1958 to 1998 in Northern Europe*1Advantages of birth cohort analysisOphthalmology, 2004
- Late diagnosis of retinoblastoma in a developing countryArchives of Disease in Childhood, 1999